Black Diamond Therapeutics

$34.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.98 (+2.93%) Today
$0.00 (0.00%) As of 1:07 PM EST after-hours

Why Robinhood?

You can buy or sell BDTX and other stocks, options, and ETFs commission-free!

About BDTX

Black Diamond Therapeutics, Inc. engages in the biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms. The company was founded by Dr. David M. Epstein and Dr. Elizabeth Buck in 2014 and is headquartered in Cambridge, MA. The listed name for BDTX is Black Diamond Therapeutics, Inc. Common Stock.

CEO
David M. Epstein
Employees
32
Headquarters
Cambridge, Massachusetts
Founded
2014
Market Cap
1.24B
Price-Earnings Ratio
Dividend Yield
Average Volume
267.03K
High Today
$34.92
Low Today
$33.50
Open Price
$33.50
Volume
109.31K
52 Week High
$46.25
52 Week Low
$17.63

Collections

BDTX Earnings

-$4.63
-$3.09
-$1.54
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 23, Pre-Market

You May Also Like